rosiglitazone has been researched along with silybin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Minhu, C; Yao, J; Zhi, M | 1 |
Shu, S; Wang, H; Wang, Q; Xu, Z | 1 |
1 trial(s) available for rosiglitazone and silybin
Article | Year |
---|---|
Danshao Shugan Granule therapy for non-alcoholic fatty liver disease.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cholesterol; Humans; Liver; Malondialdehyde; Medicine, Chinese Traditional; Mice; NF-kappa B; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Rosiglitazone; Silybin; Superoxide Dismutase; Triglycerides | 2022 |
2 other study(ies) available for rosiglitazone and silybin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of silybin on high-fat-induced fatty liver in rats.
Topics: Animals; Antioxidants; Dietary Fats; Disease Models, Animal; Drug Evaluation, Preclinical; Fatty Liver; Homeostasis; Hypoglycemic Agents; Insulin Resistance; Lipid Peroxidation; Lipids; Liver; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Rosiglitazone; Silybin; Silymarin; Thiazolidinediones | 2011 |